Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Macau

— Macau is on course to become the first of Everest’s Asian territories to get etrasimod approval — Can provide access to patients in China’s Greater Bay area and rest of Asia SHANGHAI, March 10, 2024 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.